ABC Laboratories
2
1M
1
0.04
0.50
- Areas of investment
Summary
ABC Laboratories is the famous Corporate Investor, which was founded in 1968. The leading representative office of defined Corporate Investor is situated in the Columbia. The venture was found in North America in United States.
The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2015.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Euclises Pharmaceuticals.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the ABC Laboratories, startups are often financed by St. Louis Arch Angels, Cultivation Capital, BioGenerator. The meaningful sponsors for the fund in investment in the same round are Missouri Technology Corporation, Helix Fund, Cultivation Capital. In the next rounds fund is usually obtained by Cultivation Capital, St. Louis Arch Angels, iSELECT FUND.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.04
- Follow on index
- 0.50
- Investments by industry
- Health Care (2)
- Biotechnology (2)
- Pharmaceutical (2)
- Investments by region
-
- United States (2)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Euclises Pharmaceuticals | 09 Sep 2014 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 1M | United States, Missouri, City of Saint Louis |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.